Immatics (IMTX) CMO Cedrik Britten reports option, RSU and share holdings
Rhea-AI Filing Summary
Immatics N.V. Chief Medical Officer Cedrik Michael Britten has filed an initial Form 3 detailing his equity holdings in the company. The filing lists multiple stock options to buy Ordinary Shares at exercise prices between $8.0600 and $11.0000, with expirations ranging from 2030-06-01 to 2036-01-07. Individual grants include, for example, options over 255,000 underlying Ordinary Shares at an exercise price of $10.0000 expiring on 2030-06-30, and options over 200,000 underlying Ordinary Shares at an exercise price of $9.3200 expiring on 2036-01-07. Footnotes describe vesting schedules, including options that are fully vested and others that vest over four-year periods. The filing also reports 50,000 restricted stock units, each convertible into one Ordinary Share, and 250 Ordinary Shares held directly. This Form 3 records existing positions and does not show any new purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Footnotes (1)
- These options to purchase ordinary shares of the Issuer ("Ordinary Shares," and each such option, an "Option") are fully vested. These Options are eligible to be earned based on the achievement of specified market capitalization performance hurdles and service-vesting conditions. The service-vesting conditions are satisfied as to 25% of the Options on the first anniversary of the grant date, June 30, 2020, and 6.25% of the Options on each quarterly anniversary of such date over the following three years. These Options vest 25% on the first anniversary of the grant date, December 13, 2022, then in 12 equal quarterly installments over the following three years. These Options vest 25% on the first anniversary of the grant date, December 5, 2023, then in 12 equal quarterly installments over the following three years. These Options vest 25% on the first anniversary of the grant date, December 3, 2024, then in 12 equal quarterly installments over the following three years. These Options vest 25% on the first anniversary of the grant date, January 8, 2026, then in 12 equal quarterly installments over the following three years. Each restricted stock unit ("RSU") represents a contingent right to receive one Ordinary Share. These RSUs vest in four equal annual installments on each anniversary of the grant date, January 8, 2026.